Tuya to Report Fourth Quarter 2024 Financial Results on February 26, 2025 Eastern Time

2025-02-17 Tuya Inc. HaiPress

SANTA CLARA,Calif.,Feb. 14,2025 -- Tuya Inc. ("Tuya" or the "Company") (NYSE: TUYA; HKEX: 2391),a global leading cloud platform service provider,today announced that it will report its fourth quarter 2024 unaudited financial results before the market opens on Wednesday,February 26,2025.

Tuya's management will hold a conference call at 08:00 A.M. Eastern Time on Wednesday,2025 (09:00 P.M. Hong Kong Time on the same day) to discuss the financial results. In advance of the conference call,all participants must use the following links to complete the online registration process. Upon registering,each participant will receive the dial-in information and a unique PIN (personal access code) to join the call as well as an email confirmation with the details.

Participants Online Webcast Registration: https://edge.media-server.com/mmc/p/ftbbqvsj

Participants Call Registration: https://register.vevent.com/register/BI7d279945a4c846f48483fdfc0e47a728

A live and archived webcast of the conference call will also be available at the Company's investor relations website at https://ir.tuya.com/.

About Tuya Inc.

Tuya Inc. (NYSE: TUYA; HKEX: 2391) is a global leading cloud platform service provider with a mission to build a smart solutions developer ecosystem and enable everything to be smart. Tuya has pioneered a purpose-built cloud developer platform with cloud and generative AI capabilities that delivers a full suite of offerings,including Platform-as-a-Service,or PaaS,Software-as-a-Service,or SaaS,and smart solutions for developers of smart device,commercial applications,and industries. Through its cloud developer platform,Tuya has activated a vibrant global developer community of brands,OEMs,AI agents,system integrators and independent software vendors to collectively strive for smart solutions ecosystem embodying the principles of green and low-carbon,security,high efficiency,agility,and openness.

Investor Relations Contact

Tuya Inc.


Investor Relations


E-mail: ir@tuya.com

The Blueshirt Group


Gary Dvorchak,CFA


Phone: +1 (323) 240-5796


Email: gary@blueshirtgroup.co

HL Strategy


Haiyan LI-LABBE


Email: hl@hl-strategy.com

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map